In the early 1970s it was clear that many of the inflammatory bowel diseases, such as Crohn's disease, ulcerative colitis, ulcerative sarcoma and Crohn's fexofenadine allegra associated with autoimmunity. This fexofenadine(allegra) to the identification and discovery of the immune response and its specific targets, which led to the development of many of the drugs of today. Although all the inflammatory diseases share a common mechanism of causation, it is now clear that each disease has a unique set of therapeutic targets and that a specific strategy must be employed to maximize therapeutic results and minimize side effects. In the case of the autoimmune diseases, this includes targeting the inflammation, the immune cells, and their immune receptors. An autoimmune disease is an autoimmune response to a foreign invader, typically a pathogen.

The allegra fexofenadine system, which consists of cells from the immune system and specialized tissue, is responsible for defending us from foreign pathogens. However, most infections are non-pathogenic so the immune system does not need to be mobilized. The allegra fexofenadine of skin and muscle is also regulated by the immune system. A typical immune response to invading microbes such as viruses and bacteria is a rapid, intense response to destroy the invading pathogen. However the immune system does not necessarily have the ability to destroy all of the invading microorganisms. In the late'70s, it was observed that some of the autoimmune diseases have a chronic inflammatory mechanism. For example, chronic lupus erythematosus is the most commonly found chronic inflammatory disorder, and is associated with autoimmune damage of the pancreas and pancreas-derived insulin.

Lupus erythematosus is also a precursor to Type 1 diabetes and its patients have greater incidence of diabetes. Although the autoimmune fexofenadine allegra is the same in both lupus and type 1 diabetes, the treatment strategies for Type 1 and Type 2 diabetes are different. Type 1 diabetes is characterized by a hyperglycemic and hyperinsulinemic state of the immune system; type 2 diabetes involves the immune system being chronically activated, and is associated with an increase in glucose concentrations with the progression of type 1 diabetes. In the autoimmune diseases of a peripheral skin, bone and joints, an autoimmune mechanism is also found. For example the skin diseases of psoriasis, lupus and fibromyalgia also have an autoimmunity.

In the case of osteoarthritis, a common cause of joint disease, it is believed that inflammatory cells, called osteoclasts, trigger the autoimmune process. The osteoclasts are cells in the inner lining of bone, which secrete osteoclasts-derived inflammatory mediators. The osteoclasts, which are a major component of the immune response against infection, can be stimulated or inhibited at the cellular level.


Allegra has antihistamine properties which are used to treat seasonal allergy symptoms such as sneezing, runny nose, itchy throat, or itchy, watery eyes.